Rapidly progressive glomerulonephritis historical perspective

Rapidly progressive glomerulonephritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Rapidly progressive glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray Findings
CT-scan Findings
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Rapidly progressive glomerulonephritis historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rapidly progressive glomerulonephritis historical perspective
CDC on Rapidly progressive glomerulonephritis historical perspective
Rapidly progressive glomerulonephritis historical perspective in the news
Blogs on Rapidly progressive glomerulonephritis historical perspective
Directions to Hospitals Treating Rapidly progressive glomerulonephritis
Risk calculators and risk factors for Rapidly progressive glomerulonephritis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jogeet Singh Sekhon, M.D. [2]

Overview

In 1958 Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome. They gave the anti GBM antibodies classification and discovered RPGN in these cases.In 1960s, electron microscopy and immunofluorescence helped to learn RPNG on immunological level.

Historical perspective

• Ernst Goodpasture made case reports about glomerulnophritis and pulmonary haemorrhages in 1919.
• Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome in 1958.
• They gave the anti GBM antibodies classification and discovered RPGN in these cases.
• In 1960s, electron microscopy and immunofluorescence helped to learn RPNG on immunological level.